Wednesday, February 10, 2010, 8:22am EST - Canadian Markets open in 1 hour and 8 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Caliper Life Sciences, Inc. (CALP)

On Feb 9: 3.15 USD   0.00 (0.00%)  
MORE ON CALP
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Caliper Life Sciences Inc (NGM:CALP) Delayed quote dataEdit
Last Trade: 3.15 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 3.15
Open: N/A
Bid: 0.01 x 200
Ask: 2,000.00 x 200
1y Target Est: 3.00
Day's Range: N/A - N/A
52wk Range: 0.76 - 3.60
Volume: 0
Avg Vol (3m): 64,336.5
Market Cap: 154.45M
P/E (ttm): N/A
EPS (ttm): -1.24
Div & Yield: N/A (N/A%)
Caliper Life Sciences, Inc. (CALP)
1d  5d  3m  6m  1y  2y  5y  max 
 Add CALP to Portfolio   Download Data

HEADLINES
RBC Capital Markets Expert Equity Analyst Sees "Shopping Spree" For Acquisitions Of Home Health Care And Diagnostics Companies In 2010 To 2011 Time Frame
Wall Street Transcript (Wed, Feb 3)
Caliper Life Sciences Introduces Sciclone(R) G3 Liquid Handler
PRNewswire (Mon, Jan 25)
Caliper Integrated Robotic System Featured in TIME Magazine's Top 10 Scientific Discoveries of 2009
PRNewswire (Thu, Jan 21)
LaBranche, Caliper Life Sciences: Biggest Price Gainers (LAB, CALP)
at The Wall Street Journal Online (Thu, Jan 14)
[$$] Waiting On Intel
at RealMoney by TheStreet.com (Thu, Jan 14)
CALIPER LIFE SCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure
EDGAR Online (Thu, Jan 14)
Caliper Life Sciences Announces Preliminary Results for the Fourth Quarter and 2009
PRNewswire (Thu, Jan 14)
Caliper Licenses Microfluidics IP to Becton Dickinson
PRNewswire (Mon, Jan 11)
Caliper Life Sciences to Present at the 28th Annual J.P. Morgan Healthcare Conference
PRNewswire (Tue, Jan 5)
CALIPER LIFE SCIENCES INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off
EDGAR Online (Thu, Dec 17)
More Headlines for CALP...

ANALYST
EPS Est (next year) (Dec-09) : -0.18
EPS Est (in 2 years) (Dec-10) : -0.11
Avg Rec (current)*: 1.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Caliper Life Sciences, Inc. develops and sells products and services to pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices